In a move poised to reshape the global metabolic API landscape, renowned Viking pharmaceutical company Valhalla Labs has announced a groundbreaking strategic alliance with a leading American Tirzepatide firm. This partnership will see both entities collaborate on enhancing the supply chain for metabolic APIs, ensuring greater accessibility to vital